Oligomerization of opioid receptors.

[1]  L. Devi,et al.  Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. , 2001, Trends in pharmacological sciences.

[2]  J. Javitch,et al.  Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[4]  S. Angers,et al.  Biochemical and biophysical demonstration of GPCR oligomerization in mammalian cells. , 2001, Life Science.

[5]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[7]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[8]  L. Devi,et al.  Molecular mechanisms of opioid receptor signal transduction. , 1998, British journal of anaesthesia.

[9]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.